PROS1 and COVID-19: Indeed, the effectiveness of broadly reactive antibodies has already been confirmed for COVID-19 where REGN-COV2, an antibody cocktail mixture containing 2 neutralizing antibodies targeting the RBD of the SARS-CoV-2 S protein, efficiently reduced viral load in COVID-19 patients (37).